"... The parasite can develop resistance to existing therapies, leading to relapses after treatment...."
So on some levels chronic is accepted, but...
Babesiosis, "Malaria-like" is "rare" in humans per wiki & NIH & yet hmmm, these studies do continue...
And the CDC DOES endorse drugs to take to make sure you don't get malaria when traveling:
www.cdc.gov/malaria/resources/pdf/fsp/drugs/atovaquoneproguanil.pdfHere NIH states that it is rare in humans:
www.niaid.nih.gov/topics/babesiosis/Pages/default.aspxBut this continued research is supported by the National Institutes of Health and the U.S. Department of Veterans Affairs Biomedical Laboratory Research and Development.
Is it me who is confused, or are there some mixed messages??
The Assoc professor who is noted in this study on his site states:
"There are two main topics investigated in this program: vaccine development and drug discovery..."
Hmmmm...
Should anyone want to send any relevant info, this prof does have his contact info listed:
/medicine.yale.edu/bbs/people/choukri_benmamoun-2.profileCONTACT INFO
Choukri Ben Mamoun, PhD
Office203.737.1972
[email protected]Mailing Address
Internal Medicine
PO Box 208056
333 Cedar Street
New Haven, CT 06520-8056